Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2009
12/22/2009US7635759 Gene encoding labyrinthin, a marker for cancer
12/22/2009US7635757 Nucleotide sequence which hybridizes to the complement of the specific nucleic acid molecule over its full length under conditions of incubation and encodes a polypeptide which costimulates T cell proliferation in vitro
12/22/2009US7635754 Interleukin-9 and interleukin-4 chimeric antagonist muteins and methods of using same
12/22/2009US7635752 Ablated SLAM-Dependent Entry
12/22/2009US7635749 Methods and compositions for prolonging elimination half-times of bioactive compounds
12/22/2009US7635688 Gene expression vectors; intensifier dor sequence determiantion; induce immunology response; viricides
12/22/2009US7635687 Vector system
12/22/2009US7635686 Cancer treatment with a synthetic sequences
12/22/2009US7635681 Cell-permeable peptide inhibitors of the JNK signal transduction pathway
12/22/2009US7635679 A polypeptide variant of the human HMGB1 high affinity binding domain Box-A (HMGB1 Box-A); more favorable pharmacokinetic and pharmacodynamic profiles; diagnose, prevent, or treat pathologies associated with extracellular HMGB1 and associated with RAGE ( receptor for advanced glycation end products )
12/22/2009US7635677 polypeptides related to a receptor to BAFF (a B-cell activating factor belonging to the Tumor Necrosis Factor family, which is associated with theexpression of B-cells and immunoglobulins); this receptor can be employed in the treatment of cancers, lymphomas, autoimmune diseases related to B-cells
12/22/2009US7635673 Gene expression inhibition via contacting with tyrphostin; liposomes; drug screening
12/22/2009US7635666 Methods for producing members of specific binding pairs
12/22/2009US7635582 Process for the production of triacylglycerols
12/22/2009US7635580 Using transgenic corynebacterium as bioreactor for fermentation of methionine; supplementing/enhancing animal feeds
12/22/2009US7635579 Metabolic engineering of amino acid production
12/22/2009US7635578 Sequencing; solid phase synthesis; primer hybridization
12/22/2009US7635576 CC-chemokine binding tick proteins
12/22/2009US7635569 Generating and identifying polypeptide stability, folding and/or solubility mutants comprising; mutagenizing gene sequences, expressing in host cell, determine protein structure; screening a candidate modulator
12/22/2009US7635567 Method for determination of the responsiveness of an individual to mistletoe lectin
12/22/2009US7635565 Analyzing blood type with identification of patient by genotyping
12/22/2009US7635559 Hybridization, immobilization; genotypes
12/22/2009US7635558 Method for analyzing nucleic acid and use thereof for evaluating the degree of mRNA editing of the serotonin 5-HT2C receptor
12/22/2009US7635557 Using protease digestion as diagnostic tool in detection of viral particles associated with severe acute respiratory syndrome (SARS)
12/22/2009US7635486 Where lipidation thereof is from expression of first nucleic acid sequence and protein portion thereof is from expression of second nucleic acid sequence and first and second sequences do not naturally occur together, such as a lipoprotein where first sequence encodes Borrelia lipoprotein, second, PsaA
12/22/2009US7635483 Enzymatically inactive streptococcal C5a peptidase (SCP) conjugated or linked to one or more peptides; effective in immunizing a susceptible mammal against beta-hemolytic Streptococcus
12/22/2009US7635480 Peptides for preventing, diagnosing and treating animal and/or human leptospirosis
12/22/2009US7635479 comprising fusion protein biodrug as antitumor agent; contains amino acid sequence from prokaryotic organism such as a Listeria species protein, an ActA protein, a Streptolysin protein; immunotherapy
12/22/2009US7635478 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/22/2009US7635476 Chimpanzee monoclonal antibodies and antigen binding fragments including variable region peptides; bioassay for detection of hepatitis A virus; diagnosis, treatment and prevention of hepatitis; kits
12/22/2009US7635475 Diabody-type bispecific antibody
12/22/2009US7635466 treating human cancers or tumors with biodrug; amino acid sequences; viricides; anticarcinogenic agent
12/22/2009CA2450142C Direct binding assay for identifying inhibitors of hcv polymerase
12/22/2009CA2373330C Profile searching in nucleic acid sequences using the fast fourier transformation
12/22/2009CA2354024C A recombinant vector expressing multiple costimulatory molecules and uses thereof
12/22/2009CA2336541C Modulation of polypeptide display on modified filamentous phage
12/22/2009CA2323607C Immunological methods to modulate myostatin in vertebrate subjects
12/22/2009CA2304929C Stable zymomonas mobilis xylose and arabinose fermenting strains
12/22/2009CA2297158C Methods and compounds for analyzing nucleic acids by mass spectrometry
12/22/2009CA2232542C Novel polypeptides and polynucleotides relating to the .alpha.- and .beta.-subunits of glutamate dehydrogenases and methods of use
12/22/2009CA2231349C Amplifications of chromosomal region 20q13 as a prognostic indicator in breast cancer
12/22/2009CA2216805C Control of pod dehiscence
12/22/2009CA2186144C Luciferases
12/22/2009CA2180309C Coccidiosis poultry vaccine
12/22/2009CA2145761C Nucleic acid ligands and methods for producing the same
12/22/2009CA2104871C Prad1 cyclin (cyclin d1) and its cdna
12/19/2009CA2633246A1 Identification of therapeutic agents for hiv infection
12/17/2009WO2009152529A2 Programming and reprogramming of cells
12/17/2009WO2009152500A2 Methods and compositions for mediating gene silencing
12/17/2009WO2009152480A2 Methods to treat solid tumors
12/17/2009WO2009152387A2 Compositions comprising cmyc sirna and methods of use thereof
12/17/2009WO2009152364A2 Proteins that fluoresce at infrared wavelengths or generates singlet oxygen upon illumination
12/17/2009WO2009152346A2 Compositions comprising phosphoinositide 3-kinase sirna and methods of use thereof
12/17/2009WO2009152336A1 Method of synthesizing polynucleotide variants
12/17/2009WO2009152285A1 Compositions and methods for producing fermentable carbohydrates in plants
12/17/2009WO2009152224A1 Compositions and methods of use of mitogen-activated protein kinase kinase kinase
12/17/2009WO2009152085A1 Novel bmp-12-related proteins and methods of their manufacture
12/17/2009WO2009152023A1 Novel bacillus thuringiensis gene with lepidopteran activity
12/17/2009WO2009151748A1 Novel bacillus thuringiensis gene with lepidopteran activity
12/17/2009WO2009151697A2 Compositions and processes relating to human bocavirus
12/17/2009WO2009151688A2 Direct selection of structurally defined aptamers
12/17/2009WO2009151605A1 Expression vectors
12/17/2009WO2009151600A2 Smad proteins control drosha-mediated mirna maturation
12/17/2009WO2009151591A2 Methods and compositions for generation of bax- and bak-deficient cell lines
12/17/2009WO2009151584A2 Identification of contaminating bacteria in industrial ethanol fermentations
12/17/2009WO2009151546A2 Methods for treating spinal muscular atrophy
12/17/2009WO2009151491A2 In vivo incorporation of an unnatural amino acid comprising a 1,2-aminothiol group
12/17/2009WO2009151313A1 A novel antiviral peptide against avian influenza virus h9n2
12/17/2009WO2009151207A1 Mesenchymal stem cells which express human hepatic growth factor, manufacturing method thereof, and use thereof as therapeutic agent for liver diseases
12/17/2009WO2009151172A1 Lentiviral vectors comprising ferritin gene and use thereof
12/17/2009WO2009151165A1 Recombinant sars-c o v n s p 12 and the use thereof, and the method for producing it
12/17/2009WO2009151150A1 Method for detecting or quantifying dna
12/17/2009WO2009151149A1 Method for detecting or quantifying dna
12/17/2009WO2009150858A1 Method for production of glycoprotein characterized by its sugar chain structure by utilizing silkworm
12/17/2009WO2009150856A1 Gene that imparts oxygen resistance and application thereof
12/17/2009WO2009150848A1 Method of directing the evolution of an organism
12/17/2009WO2009150839A1 Diagnosis/treatment option for head-and-neck tumor using micro-rna as biomarker
12/17/2009WO2009150835A1 Iqgap3 epitope peptides and vaccines containing the same
12/17/2009WO2009150789A1 Method for testing for the risk of coronary artery spasm
12/17/2009WO2009150550A2 Genetic component of complications in type 2 diabetes
12/17/2009WO2009150477A2 Gene transfer vehicle and use therefor
12/17/2009WO2009150470A2 Suppression of cancers
12/17/2009WO2009150469A2 Suppression of neuroendocrine diseases
12/17/2009WO2009150456A1 Protein expression
12/17/2009WO2009150442A1 Selection method ii
12/17/2009WO2009150441A1 Mitochondrial transformation
12/17/2009WO2009150435A1 Plastid transformation vectors allowing excision of marker genes
12/17/2009WO2009150431A1 Vector
12/17/2009WO2009150430A2 Vaccine
12/17/2009WO2009150426A2 Method
12/17/2009WO2009150275A1 Human anti-dectin-1 antibody, hybridoma producing said antibody and applications thereof
12/17/2009WO2009150222A2 Improved protein expression system
12/17/2009WO2009150215A2 Hybrid proteins comprising membrane receptor and ion channel, and their use as biosensors
12/17/2009WO2009150195A1 Multi-species polynucleotide control sequences
12/17/2009WO2009150170A1 Methods in increasing grain value by improving grain yield and quality
12/17/2009WO2009150156A1 Method for enzymatic synthesis of chemically modified rna
12/17/2009WO2009149956A2 Fusion protein and use thereof
12/17/2009WO2009149921A2 Inhibition of hrp-3 using modified oligonucleotides
12/17/2009WO2009149910A1 Anti-angiogenic compositions and therapeutic applications thereof
12/17/2009WO2009149787A1 Bollworm insect resistance management in transgenic plants